List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 36 studies with search of: autoimmune niaid | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder;   Canale-Smith Syndrome
Intervention:
2 Recruiting Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: ALPS;   Hypersplenism;   Lymphadenopathy
Interventions: Drug: Valproic Acid;   Procedure: CT Scan;   Procedure: Blood Sample
3 Recruiting Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
Conditions: Lymphoproliferative Disorders;   Lymphoma
Intervention:
4 Recruiting Scleroderma: Cyclophosphamide or Transplantation (SCOT)
Conditions: Scleroderma, Systemic;   Sclerosis;   Autoimmune Disease
Interventions: Procedure: Autologous stem cell transplantation and High-dose immunosuppressive therapy (HDIT);   Drug: Cyclosphosphamide;   Drug: Equine antithymocyte globulin;   Drug: Methylprednisolone;   Drug: Growth colony stimulating factor (G-CSF);   Radiation: Total body irradiation (TBI)
5 Recruiting Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
Condition: Diabetes Mellitus, Type I
Interventions: Drug: Low Molecular Weight Sulfated Dextran (LMW-SD);   Drug: Heparin;   Drug: Mycophenolate mofetil;   Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Cyclosporine;   Drug: Daclizumab;   Drug: Basiliximab
6 Recruiting Safety and Effectiveness of Low Molecular Weight Sulfated Dextran (LMW-SD) is Islet Transfusion After Kidney Transplant
Condition: Diabetes Mellitus, Type I
Interventions: Drug: Low Molecular Weight Sulfated Dextran (LMW-SD);   Drug: Heparin;   Drug: Mycopheonloate Mofetil;   Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Cyclosporine;   Drug: Daclizumab;   Drug: Basiliximab
7 Recruiting Natural History of Bronchiectasis
Conditions: Bronchiectasis;   Cystic Fibrosis;   Autoimmune Disease;   Common Variable Immunodeficiency
Intervention:
8 Recruiting Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Conditions: Idiopathic CD4+ Lymphocytopenia;   Cryptococcal Meningitis;   Warts
Intervention:
9 Recruiting Genetic Analysis of Immune Disorders
Conditions: Healthy;   Immunologic Deficiency Syndrome;   Job's Syndrome;   Severe Combined Immunodeficiency
Intervention:
10 Recruiting Etanercept for the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Etanercept;   Drug: Lupus Treatment
11 Recruiting Use of Infliximab for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Drug: Infliximab;   Drug: Prednisone;   Other: Placebo
12 Recruiting Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Antithymocyte globulin;   Drug: Placebo
13 Recruiting Efficacy of Islet After Kidney Transplantation
Condition: Type 1 Diabetes Mellitus
Interventions: Procedure: Islet transplant;   Procedure: Intensive Insulin Therapy
14 Recruiting Islet Transplantation in Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: Islet transplant
15 Recruiting B-Lymphocyte Immunotherapy in Islet Transplantation
Condition: Type 1 Diabetes Mellitus
Interventions: Procedure: Islet transplant;   Drug: Thymoglobulin (Antithymocyte globulin);   Drug: Zenapax (Daclizumab);   Drug: Rituxan (Rituximab);   Drug: Rapamune (Sirolimus)
16 Recruiting Strategies to Improve Islet Survival
Condition: Type 1 Diabetes Mellitus
Interventions: Procedure: Islet transplant;   Drug: Antithymocyte globulin;   Drug: Daclizumab;   Drug: Exenatide;   Drug: Lisofylline;   Drug: Sirolimus;   Drug: Tacrolimus
17 Recruiting Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Procedure: Islet transplant;   Drug: Deoxyspergualin;   Drug: Antithymocyte globulin;   Drug: Daclizumab or basiliximab;   Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Etanercept
18 Recruiting LEA29Y (Belatacept) Emory Edmonton Protocol
Condition: Type 1 Diabetes Mellitus
Interventions: Procedure: Islet transplant;   Drug: Belatacept;   Drug: Daclizumab or Basiliximab;   Drug: Mycophenolate Mofetil
19 Recruiting Switching Anti-TNF-Alpha Agents in RA
Condition: Rheumatoid Arthritis
Interventions: Drug: Adalimumab;   Drug: Adalimumab placebo;   Drug: Etanercept
20 Recruiting Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept;   Drug: Adalimumab

Previous Page Studies Shown (1-20) Next Page (21-36)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services